Current Issues in Molecular Biology,
Journal Year:
2024,
Volume and Issue:
46(12), P. 14366 - 14380
Published: Dec. 20, 2024
Type
2
diabetes
mellitus
(T2DM)
is
a
global
health
concern,
with
diabetic
neuropathy
(DN)
being
prevalent
complication.
Current
DN
treatments
focus
on
blood
glucose
control
and
pain
management,
which
show
limited
efficacy.
This
study
explored
the
effects
of
autologous
dendritic
cell
(DC)
administration
improving
symptoms.
A
quasi-experimental
clinical
trial
was
conducted
28
patients
at
Gatot
Soebroto
Army
Hospital.
Patients
received
DC
administration,
their
Toronto
Clinical
Neuropathy
Score
(TCNS),
Transforming
Growth
Factor-β
(TGF-β),
Vascular
Cell
Adhesion
Molecule-1
(VCAM-1)
levels
measured
before
four
weeks
after
treatment.
The
results
an
average
TCNS
reduction
from
8.93
to
7.5
(p
<
0.001).
TGF-β
increased
slightly
41.16
ng/mL
44.18
>
0.05).
VCAM-1
1389.75
1403.85
ng/mL.
Correlation
analysis
showed
that
had
significant
negative
correlation
(r
=
−0.353;
p
0.033)
−0.521;
0.002).
Autologous
significantly
improves
DN.
While
changes
in
were
not
statistically
significant,
trends
suggest
there
anti-inflammatory
effect.
These
findings
highlight
potential
therapy
as
complementary
approach
manage
through
inflammation
nerve
repair.
Biomedicines,
Journal Year:
2025,
Volume and Issue:
13(3), P. 589 - 589
Published: Feb. 28, 2025
Diabetic
peripheral
neuropathy
(DPN)
is
a
debilitating
complication
of
diabetes
mellitus,
characterized
by
progressive
nerve
damage
driven
chronic
hyperglycemia
and
systemic
inflammation.
The
pathophysiology
DPN
significantly
influenced
pro-inflammatory
cytokines,
such
as
IL-1β,
IL-6,
TNF-α.
These
cytokines
promote
oxidative
stress,
vascular
dysfunction,
neuronal
degeneration
activating
important
signaling
pathways
including
NF-κB
MAPK.
While
IL-6
promotes
microenvironment,
increasing
neuropathic
pain,
TNF-α
IL-1β
worsen
Schwann
cell
failure
compromising
axonal
support
causing
demyelination.
Immune
infiltration
TLR
activation
increase
the
inflammatory
cascade
in
DPN,
resulting
persistent
neuroinflammatory
state
that
sustains
injury.
main
characteristics
are
degeneration,
decreased
neurotrophic
support,
which
weaken
transmission
susceptibility
to
damage.
Advanced
glycation
end-products,
TNF-α,
CXCL10
examples
biomarkers
may
be
used
for
early
diagnosis
disease
progression
monitoring.
Additionally,
crucial
molecular
targets
have
been
found
using
proteomic
transcriptome
techniques,
enabling
precision
medicine
treatment
DPN.
This
review
emphasizes
importance
cytokine
pathogenesis
how
cytokine-targeted
treatments
might
reduce
inflammation,
restore
function,
improve
clinical
outcomes
diabetic
patients.
Biomedicines,
Journal Year:
2024,
Volume and Issue:
12(6), P. 1256 - 1256
Published: June 5, 2024
Nerve
injury
is
a
common
condition
that
occurs
as
result
of
trauma,
iatrogenic
injury,
or
long-lasting
stimulation.
Unlike
the
central
nervous
system
(CNS),
peripheral
(PNS)
has
strong
capacity
for
self-repair
and
regeneration.
Peripheral
nerve
results
in
degeneration
distal
axons
myelin
sheaths.
Macrophages
Schwann
cells
(SCs)
can
phagocytose
damaged
cells.
Wallerian
(WD)
makes
whole
axon
structure
degenerate,
creating
favorable
regenerative
environment
new
axons.
After
macrophages,
neutrophils
other
are
mobilized
recruited
to
site
necrotic
debris.
Pro-inflammatory
anti-inflammatory
factors
involved
inflammatory
response
provide
microenvironment
regeneration
regulate
effects
inflammation
on
body
through
relevant
signaling
pathways.
Previously,
was
thought
be
detrimental
body,
but
further
research
shown
appropriate
promotes
regeneration,
formation.
On
contrary,
excessive
cause
tissue
damage
pathological
changes,
even
lead
neurological
diseases.
Therefore,
after
various
interact
with
cytokines
chemokines
promote
repair
by
inhibiting
negative
harnessing
positive
specific
ways
at
times.
Understanding
interaction
between
neuroinflammation
provides
several
therapeutic
ideas
improve
Advanced Functional Materials,
Journal Year:
2024,
Volume and Issue:
34(38)
Published: April 12, 2024
Abstract
Peripheral
nerve
injury
often
leads
to
the
loss
of
neurological
functions
due
slow
regeneration
rate
and
inefficient
functional
reconstruction.
Current
clinical
treatments
using
guidance
conduits
(NGCs)
still
face
challenges
in
providing
a
biomimetic
microenvironment
promote
repair.
Herein,
decellularized
extracellular
matrix
(dECM)
is
obtained
from
porcine
Achilles
tendon
crosslinked
with
3‐amino‐4‐methoxybenzoic
acid
grafted
gelatin
(PAMB‐G)
obtain
conductive
hydrogels.
Then,
novel
conduit
developed
by
assembling
poly(vinyl
alcohol)
(PVA)
ECM@PAMB‐G
hydrogel.
This
bioengineered
ECM@PAMB‐G/PVA
demonstrated
excellent
cytocompatibility,
electrical
conductivity,
mechanical
properties,
biodegradability.
In
vitro
experiments
confirmed
that
hydrogel
significantly
promotes
proliferation
migration
PC12
cells
primary
Schwann
cells,
as
well
growth
dorsal
root
ganglion
(DRG)
axons.
Furthermore,
vivo
studies
rat
sciatic
model
exhibited
improvements
axonal
regeneration,
cell
migration,
myelin
sheath
formation,
recovery
mediated
conduit.
work
demonstrates
synergistic
effects
cues
enhancing
peripheral
regeneration.
The
shows
potential
an
alternative
autografts
for
supporting
Brain‐X,
Journal Year:
2025,
Volume and Issue:
3(1)
Published: Feb. 8, 2025
Abstract
As
an
etiological
factor
underlying
physical
and
mental
disability
in
humans,
peripheral
nerve
injuries
(PNIs)
can
induce
pain,
sensory
impairment,
disability.
Despite
their
regenerative
ability,
nerves
cannot
self‐repair
after
severe
defects.
While
grafting
is
the
gold
standard
for
treatment
of
PNIs,
it
limited
by
graft
versus
host
reactions,
surgical
complications,
donor
nerves.
field
material
science
continues
to
develop,
hydrogels
have
been
proposed
use
PNI
repair
biomodification,
targeted
modification,
or
loading
with
biological
factors
cells.
This
article
reviewed
research
advances
used
repair,
including
simple
composite
functionalized
loaded
Based
on
findings
from
these
reviews,
we
determined
that
further
clarification
mechanisms
action
modulating
cellular
functions
necessary.
In
addition,
there
a
need
explore
synergistic
effect
novel
other
biological,
physical,
biochemical
factors.
clinical
trials
are
still
limited,
scientific
efforts
expected
promote
application
repair.
Frontiers in Pharmacology,
Journal Year:
2025,
Volume and Issue:
16
Published: Feb. 13, 2025
Background
The
tyrosine
receptor
kinase
inhibitor
(TRKi)
entrectinib
is
used
to
treat
neurotrophic
(NTRK)
fusion-positive
solid
tumors
and
ROS1-positive
patients.
Despite
its
impressive
efficacy
against
cancer,
the
clinical
application
still
limited
by
central
nervous
system
(CNS)-related
toxicities.
However,
precise
mechanism
of
such
CNS-related
toxicities
remains
elusive.
Methods
effect
entrectinib-induced
nerve
cell
damage
was
evaluated
cells
(PC12,
HT22
SK-N-SH)
based
in
vitro
models.
Various
assays,
including
CCK-8,
colony
formation
EdU
incorporation
assays
were
utilized
estimate
cellular
viability
proliferation
ability.
Cell
apoptosis
measured
flow
cytometry.
Next,
transcriptome
sequencing
technology
performed
identify
differentially
expressed
genes
(DEGs).
Gene
ontology
(GO),
kyoto
encyclopedia
genomes
(KEGG)
analysis
gene
set
enrichment
(GSEA)
applied
predict
potential
functions
DEGs.
Quantitative
real
time
polymerase
chain
reaction
(qRT-PCR)
Western
blotting
measure
expressions
thrombospondin-1
(THBS1),
TGF-β1,
PI3K,
AKT
phosphorylated
(p-AKT)
entrectinib-treated
cells.
Additionally,
we
Preliminary
observed
validated
whether
THBS1
overexpression
could
rescue
abnormalities
PI3K-AKT
TGF-β
signaling
pathways.
Results
Entrectinib
significantly
inhibited
formation,
induced
apoptosis.
Transcriptome
qRT-PCR
revealed
that
downregulated
within
treatment.
KEGG
GSEA
also
suggested
directly
caused
proliferation-related
pathway
like
pathway,
apoptosis-related
pathway.
We
further
demonstrated
THBS1,
p-AKT
entrectinib.
Meanwhile,
pretreatment
with
plasmids
rescued
from
death
Conclusion
These
results
identified
a
critical
role
promoting
downregulating
expression
while
inhibiting
Our
findings
will
provide
therapeutic
targets
for
Brain Sciences,
Journal Year:
2025,
Volume and Issue:
15(4), P. 400 - 400
Published: April 15, 2025
Neuroplasticity,
the
ability
of
nervous
system
to
adapt
structurally
and
functionally
in
response
environmental
interactions
injuries,
is
a
cornerstone
recovery
central
(CNS)
peripheral
systems
(PNS).
This
review
explores
mechanisms
underlying
neuroplasticity,
focusing
on
dynamic
roles
cellular
molecular
processes
from
injuries.
Key
players,
including
Schwann
cells,
oligodendrocytes,
neural
stem
are
highlighted
for
their
contributions
nerve
repair,
myelination,
regeneration.
Advances
therapeutic
interventions,
such
as
electrical
stimulation,
bioluminescent
optogenetics,
innovative
grafting
techniques,
discussed
alongside
potential
enhance
functional
outcomes.
The
underpinnings
plasticity,
involving
synaptic
remodeling,
homeostatic
mechanisms,
activity-dependent
regulation
gene
expression,
elucidated
illustrate
role
learning,
memory,
injury
repair.
Integrating
emerging
technologies
approaches
with
foundational
understanding
neuroplasticity
offers
pathway
toward
more
effective
strategies
restoring
functionality
after
injury.
Frontiers in Immunology,
Journal Year:
2025,
Volume and Issue:
16
Published: Feb. 21, 2025
Peripheral
nerve
injury
(PNI)
represents
a
common
challenge
in
clinical
practice.
In
contrast
to
the
central
nervous
system
(CNS),
peripheral
(PNS)
mature
mammals
possesses
limited
regenerative
capacity.
Upon
occurrence
of
PNI,
regeneration
(PNR)
is
initiated,
facilitated
by
activation
immune
microenvironment
and
intrinsic
growth
potential
neurons.
This
process
encompasses
several
key
stages,
including
distal
axon
degeneration,
myelin
breakdown,
clearance
debris,
inflammatory
responses
from
non-neuronal
cells,
subsequent
axonal
regeneration.
The
response,
recognized
for
its
role
clearing
debris
modulating
local
milieu,
crucial
initiating
at
proximal
stump
nerves.
Nevertheless,
precise
mechanisms
which
response
influences
PNI
strategies
harness
this
augment
remain
elusive.
article
provides
comprehensive
overview
diverse
roles
PNR
presents
insights
into
therapeutic
strategies.
Furthermore,
examines
immune-associated
signaling
pathways
their
impact
on
PNR,
underscoring
significance
modulation
enhancing
patient
outcomes
with
PNI.
Ultimately,
it
encapsulates
forecasts
theoretical
practical
directions
field.
International Journal of Nanomedicine,
Journal Year:
2023,
Volume and Issue:
Volume 18, P. 6763 - 6779
Published: Nov. 1, 2023
Abstract:
Peripheral
nerve
injuries
present
significant
challenges
in
regenerative
medicine,
primarily
due
to
inherent
limitations
the
body’s
natural
healing
processes.
In
response
these
and
with
aim
of
enhancing
peripheral
regeneration,
nanofiber
scaffolds
have
emerged
as
a
promising
advanced
intervention.
However,
deeper
understanding
underlying
mechanistic
foundations
that
drive
favorable
contributions
regeneration
is
essential.
this
comprehensive
review,
we
make
an
exploration
latent
potential
augmenting
regeneration.
This
includes
detailed
introduction
fabrication
methods
nanofibers,
analysis
intricate
interactions
between
cellular
entities,
examination
strategies
related
controlled
release
bioactive
agents,
assessment
prospects
for
clinical
translation,
emerging
trends,
thorough
considerations
regarding
biocompatibility
safety.
By
comprehensively
elucidating
structural
attributes
multifaceted
functional
capacities
scaffolds,
offer
prospective
effective
strategy
treatment
injury.
Keywords:
nanofiber,
nanomedicine,
tissue
Neural Regeneration Research,
Journal Year:
2024,
Volume and Issue:
20(7), P. 1864 - 1882
Published: May 10, 2024
Nerve
regeneration
following
traumatic
peripheral
nerve
injuries
and
neuropathies
is
a
complex
process
modulated
by
diverse
factors
intricate
molecular
mechanisms.
Past
studies
have
focused
on
that
stimulate
axonal
outgrowth
myelin
regeneration.
However,
recent
highlighted
the
pivotal
role
of
autophagy
in
regeneration,
particularly
context
injuries.
Consequently,
autophagy-targeting
modulation
has
emerged
as
promising
therapeutic
approach
to
enhancing
Our
current
understanding
suggests
activating
facilitates
rapid
clearance
damaged
axons
sheaths,
thereby
neuronal
survival
mitigating
injury-induced
oxidative
stress
inflammation.
These
actions
collectively
contribute
creating
favorable
microenvironment
for
structural
functional
A
range
autophagy-inducing
drugs
interventions
demonstrated
beneficial
effects
alleviating
neuropathy
promoting
preclinical
models
This
review
delves
into
regulation
cell
types
involved
summarizing
potential
can
be
harnessed
promote
this
process.
We
hope
our
will
offer
novel
insights
perspectives
exploitation
pathways
treatment
neuropathies.
World Journal of Stem Cells,
Journal Year:
2024,
Volume and Issue:
16(5), P. 467 - 478
Published: May 23, 2024
Unlike
central
nervous
system
injuries,
peripheral
nerve
injuries
(PNIs)
are
often
characterized
by
more
or
less
successful
axonal
regeneration.
However,
structural
and
functional
recovery
is
a
senile
process
involving
multifaceted
cellular
molecular
processes.
The
contemporary
treatment
options
limited,
with
surgical
intervention
as
the
gold-standard
method;
however,
each
option
has
its
associated
limitations,
especially
when
injury
severe
large
gap.
Recent
advancements
in
cell-based
therapy
cell-free
approaches
using
stem
cell-derived
soluble
insoluble
components
of
cell
secretome
fast-emerging
therapeutic
to
treating
acute
chronic
PNI.
recent
pilot
study
leap
forward
field,
which
expected
pave
way
for
enormous,
systematic,
well-designed
clinical
trials
assess
efficacy
mesenchymal
exosomes
bio-drug
either
alone
part
combinatorial
approach,
an
attempt
synergize
best
novel
address
complexity
neural
repair